ABEO
NASDAQ · Biotechnology
Abeona Therapeutics Inc
$6.18
+0.52 (+9.19%)
Open$5.66
Previous Close$5.66
Day High$6.25
Day Low$5.66
52W High$7.54
52W Low$4.00
Volume—
Avg Volume1.23M
Market Cap321.17M
P/E Ratio4.86
EPS$0.87
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+128.0% upside
Current
$6.18
$6.18
Target
$14.09
$14.09
$7.81
$14.09 avg
$15.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.90M | 3.05M | 39.71M |
| Net Income | 59.91M | 33.61M | -4,431,314 |
| Profit Margin | 1,223.1% | 1,161.9% | -11.2% |
| EBITDA | 55.10M | 32.63M | -4,969,444 |
| Free Cash Flow | — | — | -4,447,710 |
| Rev Growth | +60.4% | +60.4% | +12.5% |
| Debt/Equity | 0.13 | 0.13 | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |